Crispr Therapeutics shares owned by Yarbrough Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Yarbrough Capital
from 13F filings
Historical chart of Yarbrough Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Yarbrough Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Yarbrough Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $331k | 8.4k | 39.36 |
| 2024-09-30 | $395k | 8.4k | 46.98 |
| 2024-06-30 | $454k | 8.4k | 54.01 |
| 2024-03-31 | $579k | 8.5k | 68.16 |
| 2023-12-31 | $532k | 8.5k | 62.60 |
| 2023-09-30 | $386k | 8.5k | 45.39 |
| 2023-06-30 | $477k | 8.5k | 56.14 |
| 2023-03-31 | $384k | 8.5k | 45.23 |
| 2022-12-31 | $4.1k | 100 | 40.65 |
| 2021-12-31 | $1.8M | 24k | 75.77 |